200 related articles for article (PubMed ID: 17434303)
1. Synthesis and biological activity of naphthalene analogues of phenstatins: naphthylphenstatins.
Alvarez C; Alvarez R; Corchete P; Pérez-Melero C; Peláez R; Medarde M
Bioorg Med Chem Lett; 2007 Jun; 17(12):3417-20. PubMed ID: 17434303
[TBL] [Abstract][Full Text] [Related]
2. Naphthylphenstatins as tubulin ligands: synthesis and biological evaluation.
Alvarez C; Alvarez R; Corchete P; Pérez-Melero C; Peláez R; Medarde M
Bioorg Med Chem; 2008 Oct; 16(19):8999-9008. PubMed ID: 18790642
[TBL] [Abstract][Full Text] [Related]
3. Naphthalene combretastatin analogues: synthesis, cytotoxicity and antitubulin activity.
Medarde M; Maya AB; Pérez-Melero C
J Enzyme Inhib Med Chem; 2004 Dec; 19(6):521-40. PubMed ID: 15662956
[TBL] [Abstract][Full Text] [Related]
4. Further naphthylcombretastatins. An investigation on the role of the naphthalene moiety.
Maya AB; Pérez-Melero C; Mateo C; Alonso D; Fernández JL; Gajate C; Mollinedo F; Peláez R; Caballero E; Medarde M
J Med Chem; 2005 Jan; 48(2):556-68. PubMed ID: 15658869
[TBL] [Abstract][Full Text] [Related]
5. Isocombretastatins A: 1,1-diarylethenes as potent inhibitors of tubulin polymerization and cytotoxic compounds.
Alvarez R; Alvarez C; Mollinedo F; Sierra BG; Medarde M; Peláez R
Bioorg Med Chem; 2009 Sep; 17(17):6422-31. PubMed ID: 19647439
[TBL] [Abstract][Full Text] [Related]
6. A new family of quinoline and quinoxaline analogues of combretastatins.
Pérez-Melero C; Maya AB; del Rey B; Peláez R; Caballero E; Medarde M
Bioorg Med Chem Lett; 2004 Jul; 14(14):3771-4. PubMed ID: 15203159
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, biological evaluation and molecular modeling of 1,3,4-oxadiazoline analogs of combretastatin-A4 as novel antitubulin agents.
Hu Y; Lu X; Chen K; Yan R; Li QS; Zhu HL
Bioorg Med Chem; 2012 Jan; 20(2):903-9. PubMed ID: 22192936
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological activity of mustard derivatives of combretastatins.
Coggiola B; Pagliai F; Allegrone G; Genazzani AA; Tron GC
Bioorg Med Chem Lett; 2005 Aug; 15(15):3551-4. PubMed ID: 15963722
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of novel vicinal diaryl-substituted 1H-Pyrazole analogues of combretastatin A-4 as highly potent tubulin polymerization inhibitors.
Romagnoli R; Oliva P; Salvador MK; Camacho ME; Padroni C; Brancale A; Ferla S; Hamel E; Ronca R; Grillo E; Bortolozzi R; Rruga F; Mariotto E; Viola G
Eur J Med Chem; 2019 Nov; 181():111577. PubMed ID: 31400707
[TBL] [Abstract][Full Text] [Related]
10. New naphthylcombretastatins. Modifications on the ethylene bridge.
Sánchez Maya AB; Pérez-Melero C; Salvador N; Peláez R; Caballero E; Medarde M
Bioorg Med Chem; 2005 Mar; 13(6):2097-107. PubMed ID: 15727863
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and cytotoxic activities of naphthyl analogues of combretastatin A-4.
Maya AB; del Rey B; Lamamie de Clairac RP; Caballero E; Barasoain I; Andreu JM; Medarde M
Bioorg Med Chem Lett; 2000 Nov; 10(22):2549-51. PubMed ID: 11086727
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of dihydronaphthalene and benzosuberene analogs of the combretastatins as inhibitors of tubulin polymerization in cancer chemotherapy.
Sriram M; Hall JJ; Grohmann NC; Strecker TE; Wootton T; Franken A; Trawick ML; Pinney KG
Bioorg Med Chem; 2008 Sep; 16(17):8161-71. PubMed ID: 18722127
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, biochemical, and biological evaluation of nitrogen-containing trifluoro structural modifications of combretastatin A-4.
Hall JJ; Sriram M; Strecker TE; Tidmore JK; Jelinek CJ; Kumar GD; Hadimani MB; Pettit GR; Chaplin DJ; Trawick ML; Pinney KG
Bioorg Med Chem Lett; 2008 Sep; 18(18):5146-9. PubMed ID: 18710804
[TBL] [Abstract][Full Text] [Related]
14. Conformationnally restricted naphthalene derivatives type isocombretastatin A-4 and isoerianin analogues: synthesis, cytotoxicity and antitubulin activity.
Rasolofonjatovo E; Provot O; Hamze A; Rodrigo J; Bignon J; Wdzieczak-Bakala J; Desravines D; Dubois J; Brion JD; Alami M
Eur J Med Chem; 2012 Jun; 52():22-32. PubMed ID: 22449653
[TBL] [Abstract][Full Text] [Related]
15. Regioselective Suzuki coupling of dihaloheteroaromatic compounds as a rapid strategy to synthesize potent rigid combretastatin analogues.
Theeramunkong S; Caldarelli A; Massarotti A; Aprile S; Caprioglio D; Zaninetti R; Teruggi A; Pirali T; Grosa G; Tron GC; Genazzani AA
J Med Chem; 2011 Jul; 54(14):4977-86. PubMed ID: 21696175
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents.
Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA
Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783
[TBL] [Abstract][Full Text] [Related]
17. Pyrazolone-fused combretastatins and their precursors: synthesis, cytotoxicity, antitubulin activity and molecular modeling studies.
Burja B; Cimbora-Zovko T; Tomić S; Jelusić T; Kocevar M; Polanc S; Osmak M
Bioorg Med Chem; 2010 Apr; 18(7):2375-87. PubMed ID: 20338766
[TBL] [Abstract][Full Text] [Related]
18. Conformationally restricted macrocyclic analogues of combretastatins.
Mateo C; Alvarez R; Pérez-Melero C; Peláez R; Medarde M
Bioorg Med Chem Lett; 2007 Nov; 17(22):6316-20. PubMed ID: 17889536
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of double bond substituted combretastatins.
Hadfield JA; Gaukroger K; Hirst N; Weston AP; Lawrence NJ; McGown AT
Eur J Med Chem; 2005 Jun; 40(6):529-41. PubMed ID: 15922837
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological studies of novel tubulin inhibitors.
Sun Y; Pandit B; Chettiar SN; Etter JP; Lewis A; Johnsamuel J; Li PK
Bioorg Med Chem Lett; 2013 Aug; 23(15):4465-8. PubMed ID: 23790539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
